Answers are grounded in this paper and cite their sources.
The clustered regularly interspaced short palindromic repeat (CRISPR)/Cas system, initially identified as a bacterial adaptive immune mechanism, has emerged as a revolutionary tool in genome editing and molecular diagnostics. This review highlights recent advancements in engineering CRISPR/Cas systems to improve specificity in nucleic acid detection, particularly in single‐base differences analysis. Mainly focus on Cas protein engineering (e.g., structure‐guided mutagenesis, directed evolution) and guide RNA (gRNA) optimization (e.g., mismatch introduction, chemical modifications). Integration of artificial intelligence tools, such as AlphaFold3 for structural prediction and machine learning for guide RNA design, may accelerate CRISPR/Cas system optimization. Despite progress, challenges persist in balancing specificity with efficiency and translating these technologies into clinical practice. By bridging computational innovation with experimental validation, CRISPR/Cas systems are poised to advance portable, scalable molecular diagnostics for precision medicine.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: